Bernard Hanseeuw, Ph.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 51 | 2022 | 7097 | 3.330 |
Why?
|
| Amyloid beta-Peptides | 44 | 2022 | 3160 | 3.010 |
Why?
|
| Tauopathies | 9 | 2021 | 291 | 2.290 |
Why?
|
| tau Proteins | 30 | 2022 | 1629 | 2.250 |
Why?
|
| Memory Disorders | 8 | 2020 | 1137 | 1.830 |
Why?
|
| Positron-Emission Tomography | 44 | 2022 | 6123 | 1.420 |
Why?
|
| Agnosia | 3 | 2020 | 62 | 1.120 |
Why?
|
| Amnesia | 3 | 2012 | 241 | 1.080 |
Why?
|
| Amyloid | 3 | 2021 | 703 | 0.990 |
Why?
|
| Hippocampus | 11 | 2021 | 3653 | 0.960 |
Why?
|
| Corpus Striatum | 2 | 2019 | 1255 | 0.890 |
Why?
|
| Aniline Compounds | 16 | 2021 | 953 | 0.840 |
Why?
|
| Amyloidosis | 2 | 2018 | 784 | 0.840 |
Why?
|
| Memory | 7 | 2020 | 2152 | 0.760 |
Why?
|
| Apolipoprotein E4 | 7 | 2022 | 610 | 0.700 |
Why?
|
| Cerebral Cortex | 8 | 2020 | 5713 | 0.660 |
Why?
|
| Brain | 27 | 2022 | 24936 | 0.660 |
Why?
|
| Heterozygote | 5 | 2022 | 2786 | 0.650 |
Why?
|
| Truth Disclosure | 1 | 2020 | 439 | 0.590 |
Why?
|
| Health | 1 | 2018 | 398 | 0.550 |
Why?
|
| Fluorodeoxyglucose F18 | 5 | 2017 | 1994 | 0.540 |
Why?
|
| Thiazoles | 13 | 2019 | 1551 | 0.510 |
Why?
|
| Neuropsychological Tests | 13 | 2019 | 6969 | 0.490 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 919 | 0.490 |
Why?
|
| Dementia | 3 | 2020 | 2211 | 0.470 |
Why?
|
| Association Learning | 2 | 2015 | 239 | 0.460 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2011 | 22 | 0.450 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2011 | 61 | 0.430 |
Why?
|
| Belgium | 6 | 2021 | 98 | 0.420 |
Why?
|
| Radiopharmaceuticals | 6 | 2020 | 2710 | 0.410 |
Why?
|
| Aged | 52 | 2022 | 162592 | 0.380 |
Why?
|
| Linguistics | 1 | 2009 | 94 | 0.380 |
Why?
|
| Peptide Fragments | 6 | 2022 | 5136 | 0.370 |
Why?
|
| Aging | 5 | 2020 | 8309 | 0.370 |
Why?
|
| Apolipoproteins E | 4 | 2019 | 1462 | 0.370 |
Why?
|
| Language Disorders | 1 | 2009 | 131 | 0.360 |
Why?
|
| Plaque, Amyloid | 3 | 2021 | 680 | 0.360 |
Why?
|
| Cognition Disorders | 4 | 2018 | 4010 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 24 | 2022 | 34096 | 0.340 |
Why?
|
| Atrophy | 5 | 2022 | 1493 | 0.340 |
Why?
|
| Aged, 80 and over | 32 | 2022 | 58752 | 0.340 |
Why?
|
| Entorhinal Cortex | 5 | 2020 | 250 | 0.320 |
Why?
|
| Anxiety | 2 | 2018 | 3880 | 0.320 |
Why?
|
| Disease Progression | 11 | 2020 | 13298 | 0.300 |
Why?
|
| Presenilin-1 | 2 | 2020 | 641 | 0.300 |
Why?
|
| Temporal Lobe | 8 | 2021 | 1650 | 0.280 |
Why?
|
| Benzothiazoles | 3 | 2021 | 248 | 0.270 |
Why?
|
| Male | 57 | 2022 | 351848 | 0.270 |
Why?
|
| Female | 57 | 2022 | 377269 | 0.250 |
Why?
|
| Humans | 77 | 2022 | 709431 | 0.250 |
Why?
|
| Awareness | 2 | 2017 | 600 | 0.240 |
Why?
|
| Early Diagnosis | 2 | 2020 | 1193 | 0.230 |
Why?
|
| Thyroiditis | 1 | 2022 | 92 | 0.220 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2022 | 93 | 0.220 |
Why?
|
| Presenilins | 1 | 2021 | 65 | 0.210 |
Why?
|
| Attention | 1 | 2012 | 2442 | 0.210 |
Why?
|
| Carbolines | 5 | 2020 | 258 | 0.210 |
Why?
|
| Longitudinal Studies | 11 | 2022 | 13595 | 0.200 |
Why?
|
| Cues | 3 | 2016 | 845 | 0.200 |
Why?
|
| Parahippocampal Gyrus | 1 | 2020 | 121 | 0.190 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 202 | 0.190 |
Why?
|
| Euthanasia, Active, Voluntary | 1 | 2019 | 11 | 0.190 |
Why?
|
| Codon | 1 | 2021 | 623 | 0.180 |
Why?
|
| Mental Recall | 3 | 2016 | 1199 | 0.180 |
Why?
|
| Leukoencephalopathies | 1 | 2022 | 253 | 0.180 |
Why?
|
| Occipital Lobe | 3 | 2020 | 382 | 0.180 |
Why?
|
| Middle Aged | 28 | 2022 | 215428 | 0.170 |
Why?
|
| Diagnostic Self Evaluation | 2 | 2017 | 230 | 0.170 |
Why?
|
| Apathy | 1 | 2019 | 91 | 0.170 |
Why?
|
| Judgment | 1 | 2020 | 287 | 0.160 |
Why?
|
| Thiones | 1 | 2017 | 49 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 601 | 0.160 |
Why?
|
| Loneliness | 1 | 2018 | 141 | 0.160 |
Why?
|
| Luminescent Measurements | 1 | 2019 | 384 | 0.160 |
Why?
|
| Palmitates | 1 | 2017 | 76 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2021 | 8971 | 0.160 |
Why?
|
| Functional Laterality | 2 | 2015 | 2308 | 0.160 |
Why?
|
| Face | 2 | 2013 | 965 | 0.150 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2016 | 91 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 1 | 2019 | 1890 | 0.140 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 22944 | 0.140 |
Why?
|
| Colombia | 3 | 2021 | 247 | 0.140 |
Why?
|
| Dominance, Cerebral | 2 | 2013 | 664 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14895 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 989 | 0.120 |
Why?
|
| Microglia | 1 | 2021 | 1160 | 0.120 |
Why?
|
| Smell | 1 | 2015 | 242 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2015 | 191 | 0.120 |
Why?
|
| Automobile Driving | 1 | 2017 | 418 | 0.120 |
Why?
|
| Sex Characteristics | 2 | 2020 | 2497 | 0.110 |
Why?
|
| Physical Examination | 1 | 2017 | 1249 | 0.100 |
Why?
|
| Alleles | 2 | 2022 | 7123 | 0.100 |
Why?
|
| Asymptomatic Diseases | 3 | 2019 | 578 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1428 | 0.100 |
Why?
|
| Dentate Gyrus | 1 | 2011 | 163 | 0.100 |
Why?
|
| Prospective Studies | 5 | 2022 | 50734 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1621 | 0.100 |
Why?
|
| Language Tests | 1 | 2009 | 191 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2317 | 0.090 |
Why?
|
| Pattern Recognition, Visual | 2 | 2013 | 831 | 0.090 |
Why?
|
| Phonetics | 1 | 2009 | 193 | 0.090 |
Why?
|
| Neurofibrillary Tangles | 2 | 2021 | 431 | 0.090 |
Why?
|
| Ethylene Glycols | 2 | 2019 | 161 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2020 | 1775 | 0.090 |
Why?
|
| ROC Curve | 1 | 2016 | 3537 | 0.090 |
Why?
|
| Nerve Net | 2 | 2017 | 2147 | 0.080 |
Why?
|
| Amyloidogenic Proteins | 2 | 2020 | 88 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2018 | 1277 | 0.080 |
Why?
|
| Adult | 11 | 2022 | 212298 | 0.080 |
Why?
|
| Risk | 4 | 2021 | 9813 | 0.080 |
Why?
|
| Software | 1 | 2021 | 4351 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 39394 | 0.080 |
Why?
|
| Visual Fields | 1 | 2013 | 1021 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3427 | 0.070 |
Why?
|
| Brain Mapping | 3 | 2018 | 6548 | 0.060 |
Why?
|
| Organ Size | 2 | 2022 | 2320 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2011 | 2000 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 16161 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4003 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 6420 | 0.060 |
Why?
|
| Parietal Lobe | 2 | 2017 | 820 | 0.060 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 11673 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 29148 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18384 | 0.050 |
Why?
|
| Contrast Media | 3 | 2019 | 5260 | 0.050 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 113 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17347 | 0.050 |
Why?
|
| Gangliosides | 1 | 2020 | 142 | 0.050 |
Why?
|
| Cricetulus | 1 | 2021 | 853 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2020 | 255 | 0.050 |
Why?
|
| CHO Cells | 1 | 2021 | 1443 | 0.040 |
Why?
|
| Cognition | 3 | 2022 | 5948 | 0.040 |
Why?
|
| Phenanthrolines | 1 | 2017 | 54 | 0.040 |
Why?
|
| Depression | 1 | 2018 | 7201 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 2020 | 284 | 0.040 |
Why?
|
| Radiculopathy | 1 | 2020 | 199 | 0.040 |
Why?
|
| Advance Directives | 1 | 2019 | 227 | 0.040 |
Why?
|
| Linear Models | 2 | 2019 | 6012 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2020 | 960 | 0.040 |
Why?
|
| Encephalitis | 1 | 2020 | 441 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2017 | 315 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 790 | 0.040 |
Why?
|
| Brain Stem | 1 | 2022 | 848 | 0.040 |
Why?
|
| Semantics | 1 | 2019 | 597 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2021 | 1140 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2016 | 238 | 0.030 |
Why?
|
| Behavior | 1 | 2017 | 560 | 0.030 |
Why?
|
| Limbic System | 1 | 2017 | 441 | 0.030 |
Why?
|
| Psychophysics | 1 | 2015 | 307 | 0.030 |
Why?
|
| Neocortex | 1 | 2017 | 389 | 0.030 |
Why?
|
| Disclosure | 1 | 2020 | 738 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10744 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 460 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2195 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 14054 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3365 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 404 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1173 | 0.030 |
Why?
|
| Trigeminal Nerve | 1 | 2015 | 260 | 0.030 |
Why?
|
| Age Factors | 2 | 2022 | 18954 | 0.030 |
Why?
|
| Counseling | 1 | 2020 | 1500 | 0.030 |
Why?
|
| Antibodies | 1 | 2020 | 2472 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 876 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2019 | 5749 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2963 | 0.030 |
Why?
|
| Forecasting | 1 | 2020 | 2957 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 826 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2017 | 1424 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2017 | 1084 | 0.030 |
Why?
|
| Learning | 1 | 2020 | 1587 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2018 | 39650 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2021 | 4312 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2015 | 1184 | 0.020 |
Why?
|
| Brain Waves | 1 | 2015 | 393 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 1952 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2017 | 858 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3192 | 0.020 |
Why?
|
| Delirium | 1 | 2020 | 1418 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 2009 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9966 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 2156 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2015 | 2027 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3412 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 70264 | 0.020 |
Why?
|
| Boston | 1 | 2021 | 9409 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2012 | 590 | 0.020 |
Why?
|
| Terminal Care | 1 | 2019 | 1618 | 0.020 |
Why?
|
| Genotype | 1 | 2022 | 12955 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2017 | 1845 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21874 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56163 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 4605 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3665 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13351 | 0.020 |
Why?
|
| Adolescent | 3 | 2022 | 85327 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8737 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2020 | 6684 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 2750 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 17087 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8019 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3890 | 0.020 |
Why?
|
| Mice | 2 | 2021 | 80950 | 0.020 |
Why?
|
| Animals | 3 | 2021 | 170647 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9802 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2020 | 8101 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2021 | 71151 | 0.010 |
Why?
|
| Neurons | 1 | 2021 | 9397 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12442 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 9948 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 15548 | 0.010 |
Why?
|
| Mutation | 1 | 2022 | 29242 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23519 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 41295 | 0.010 |
Why?
|
| Child | 1 | 2019 | 73998 | 0.010 |
Why?
|